EQUITY Equity (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2026:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Cumulative Foreign Currency Translation Adjustments |
|
Total |
|
(in thousands) |
| Balance at December 31, 2025 |
$ |
3,872 |
|
|
$ |
(118,744) |
|
|
$ |
(114,872) |
|
Other comprehensive income (loss) before reclassifications |
1,097 |
|
|
(23,050) |
|
|
(21,953) |
|
| Amount reclassified from AOCI |
(5,241) |
|
|
— |
|
|
(5,241) |
|
| Net other comprehensive loss |
(4,144) |
|
|
(23,050) |
|
|
(27,194) |
|
| Balance at June 30, 2026 |
$ |
(272) |
|
|
$ |
(141,794) |
|
|
$ |
(142,066) |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
|
|
|
|
|
|
|
| Restricted stock and deferred stock—unvested |
696,934 |
|
|
1,188,300 |
|
|
3,171,415 |
|
|
1,188,300 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
11,944,810 |
|
|
14,946,450 |
|
|
21,170,304 |
|
|
14,946,450 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
12,641,744 |
|
|
16,134,750 |
|
|
24,341,719 |
|
|
16,134,750 |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
|
| Weighted average common shares—basic |
232,838,912 |
|
|
231,845,412 |
|
|
232,621,161 |
|
|
231,534,852 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
1,971,925 |
|
|
2,572,016 |
|
|
— |
|
|
2,930,952 |
|
| Convertible senior notes |
9,225,494 |
|
|
— |
|
|
— |
|
|
192,804 |
|
| Weighted average common shares—diluted |
244,036,331 |
|
|
234,417,428 |
|
|
232,621,161 |
|
|
234,658,608 |
|
|